Opna BIO

Opna Bio was formed by an accomplished team of biotech executives around a groundbreaking new discovery – the novel oncology target fragile X mental retardation protein (FMRP). FMRP research was led by one of Opna’s co-founders, a renowned scientist and co-author of the pioneering “Hallmarks of Cancer” series.

Referred to us by Longitude Capital, the Opna Bio team needed an corporate presentation and a website to launch the company in time for the release of the FMRP publication in Science magazine. They wanted our help in developing a corporate story that would cohesively combine their novel scientific discovery with the existing pipeline of oncology programs. 

As a result, the story we developed revolves around the Hallmarks of Cancer and ties together the novel and known cancer targets reflected in Opna’s pipeline. We developed their corporate presentation and website, designed multiple scientific illustrations, and led the re-branding effort for Opna Bio’s company and new scientific discovery launch.

To learn more about this project and working with us, please see our Opna Bio case study.